Cargando…
High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease
The immunomodulatory potential and low incidence of severe side effects of high-dose intravenous immunoglobulin (IVIg) treatment led to its successful application in a variety of dermatological autoimmune diseases over the last two decades. IVIg is usually administered at a dose of 2 g per kg body w...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579842/ https://www.ncbi.nlm.nih.gov/pubmed/31244821 http://dx.doi.org/10.3389/fimmu.2019.01090 |